Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 25, 2008, Pages 8709-8712

  Kubler Kielb, Joanna ^a   Vinogradov, Evgeny ^b   Hu, Haijing ^c   Leppla, Stephen H ^c   Robbins, John B ^a   Schneerson, Rachel ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Anthrose; Capsule; Flagellae; Pseudomonas syringae; Shewanella

Indexed keywords

3 HYDROXYBUTYRIC ACID; ANTHRAX VACCINE; ANTHROSE; ANTISERUM; CAPSULAR POLYSACCHARIDE; CARBOHYDRATE; CARBOHYDRATE DERIVATIVE; GLYCOPROTEIN; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACTERIAL CELL; BACTERIAL SPORE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLAGELLUM; FLUORESCENCE MICROSCOPY; IMMUNIZATION; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS SYRINGAE; SHEWANELLA;

ANIMALS; ANTHRAX VACCINES; BACILLUS ANTHRACIS; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICROSCOPY, FLUORESCENCE; OLIGOSACCHARIDES; SHEWANELLA; SPORES, BACTERIAL;

BACILLUS (BACTERIUM); BACILLUS ANTHRACIS; BACILLUS CEREUS; BACTERIA (MICROORGANISMS); MAMMALIA; PSEUDOMONAS SYRINGAE; SHEWANELLA;

EID: 47349087254     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0803897105     Document Type: Article

References (30)

1. Spencer RC (2003) Bacillus anthracis. J Clin Pathol 56:182-187.
2. Scorpio A, Blank TE, Day WA, Chabot DJ (2006) Anthrax vaccines: Pasteur to the present. Cell Mol Life Sci 63:2237-2248.
3. Williams RP (1986) Bacillus anthracis and other spore forming bacilli. Infectious Disease and Medical Microbiology, eds Braude Al, Davis LE, Fierer J (Saunders, Philadelphia), pp 270-278.
4. Daubenspeck JM, et al. (2004) Novel oligosaccharide side chains of the collagen-like region of BclA, the major glycoprotein of the Bacillus anthracis exosporium. J Biol Chem 279:30945-30953.
5. Mehta AS, et al. (2006) Synthesis and antigenic analysis of the BclA glycoprotein oligosaccharide from the Bacillus anthracis exosporium. Chemistry 12:9136-9149.
6. Saksena R, Adamo R, Kov́c P (2005) Studies toward a conjugate vaccine for anthrax. Synthesis and characterization of anthrose [4,6-dideoxy-4-(3-hydroxy-3-methylbu-tanamido)-2-0-methyl-D-glucopyranose] and its methyl glycosides. Carbohydr Res 340:1591-1600.
7. Werz DB, Seeberger PH (2005) Total synthesis of antigen Bacillus anthracis tetrasac-charide - creation of an anthrax vaccine candidate. AngewChem IntEdEngl 44:6315-6318.
8. Crich D, Vinigradova O (2007) Synthesis pf the antigenic tetrasaccharide side chain from the major glycoprotein of Bacillus anthracis exosporium. J Org Chem 72:6513-6520.
9. Tamborrini M, Werz DB, Frey J, Pluschke G, Seeberger PH (2006) Anti-carbohydrate antibodies for the detection of anthrax spores. Angew Chem Int Ed Engl 45:6581-6582.
10. Vinogradov E, Nossova L, Korenevsky A, Beveridge TJ (2005) The structure of the capsular polysaccharide of Shewanella oneidensis strain MR-4. Carbohydr Res 340:1750-1753.
11. Takeuchi K,etal. (2007) Flagellin glycans from two pathovars of Pseudomonas syringae contain rhamnose in D and L configurations in different ratios and modified 4-amino-4,6-dideoxyglucose. J Bacteriol 189:6945-6956.
12. Vinogradov E, et al. (1991) Somatic antigens of pseudomonads: Structure of the O-specific polysaccharide chain of Pseudomonas syringae pv. tabaci 225 (serogroup VIII) lipopolysaccharide. Carbohydr Res 212:307-311.
13. Dong S, et al. (2008) Anthrose biosynthetic operon of Bacillus anthracis. J Bacteriol 190:2350-2359.
14. Enkhtuya J, et al. (2006) Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids. Microbiology 152:3103-3110.
15. Brossier F, Levy M, Mock M (2002) Anthrax spores make an essential contribution to vaccine efficacy. Infect Immun 70:661-664.
16. Cohen S, et al. (2000) Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun 68:4549-4558.
17. Singer DE, et al. (2008) Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel. Vaccine 26:869-873.
18. Bradshaw MW, Schneerson R, Parke JC, Jr, Robbins JB (1971) Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b. Lancet 1:1095-1096.
19. Pomerantsev A, Sitaraman R, Galloway CR, Kivovich V, Leppla SH (2006) Genome engineering in Bacillus anthracis using cre recombinase. Infect Immun 74:682-693.
20. Ruhfel RE, Robillard NJ, ThorneCB (1984) Interspecies transduction of plasmids among Bacillus anthracis, B cereus, and B thuringiensis. J Bacteriol 157:708-711.
21. RodriguesLP, Schneerson R, RobbinsJB (1971) Immunity to Hemophilus influenzae type b. I. The isolation, and some physicochemical, serologic and biologic properties of the capsular polysaccharide of Hemophilus influenzae type b. J Immunol 107:1071-1080.
22. Taguchi F, et al. (2006) Identification of glycosylation genes and glycosylated amino acids of flagellin in Pseudomonas syringae pv. tabaci. Cell Microbiol 8:923-938.
23. Westphal O, Jann K(1965) Extraction with phenol-water and further application of the procedure. Methods Carbohydr Chem 5:83-91.
24. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28:350-356.
25. Lowry JO, Rosenbrough NJ, Farr AL, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
26. Schneerson R, Barrera O, Sutton A, RobbinsJB (1980) Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med 152:361-376.
27. Chu CY, et al. (1991) Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid. Infect Immun 59:4450-4458.
28. Zielen S, et al. (1996) Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA plates. J Immunol Methods 193:1-7.
29. Schaeffer P, lonesco H, Ryter A, Balassa G (1963) Sporulation of Bacillus subtil is: Genetic and physiological study. Colloq Int CNRS 124:553-563.
30. Hu H, Sa Q, Koehler TM, Aronson Al, Zhou D (2006) Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell Microbiol 8:1634-1642.